Startups
Innovation and effectiveness for the treatment of rare and ultra-rare diseases. Background Atlas Molecular Pharma was founded in Biscay (Spain) in September 2015 as a spin-off company of the Centre for Co-operative Research in Biosciences (CIC bioGUNE).Our business model is to discover first-in-class, innovative therapeutics for the treatment of Rare and Ultra-Rare Diseases and license […]
Overview
Location
Spain, Autonomous Community of the Basque Country, Derio
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Feb 1, 2022 | Atlas Molecular Pharma cierra una ronda de €3M liderada por Inveready, CDTI y EZTEN. Acuden también socios actuales | 01/02/2022 Nota de prensa ATLAS MOLECULAR PHARMA CIERRA UNA RONDA DE €3 MILLONES LIDERADA POR INVEREADY PARA AVANZAR EL DESARROLLO CLÍNICO DE SU PRIMER CANDIDATO. Inveready, a través de su vehículo Inveready Biotech III, lidera la ronda ... |
Reviews 0
FAQ about Atlas Molecular Pharma
What has the press written about Atlas Molecular Pharma?
Parsers VC has collected 2 articles mentioning Atlas Molecular Pharma, among them “Atlas Molecular Pharma cierra una ronda de €3M liderada por Inveready, CDTI y EZTEN. Acuden también socios actuales” (Feb 1, 2022).
Is Atlas Molecular Pharma still active?
Yes, Atlas Molecular Pharma is active; its latest activity on Parsers VC dates from Apr 18, 2023.